Enliven Therapeutics Inc (ELVN)

Operating Expenses

$37.21M

Quarterly · Period ending: · USD

ELVN logo

ELVN Operating Expenses

Latest reported$37.21M
ELVN Quarterly Operating Expenses ($4.19M → $37.21M)
High-resolution chart · PNG

ELVN operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Enliven Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
37,209,000
27,823,000
34,239,000
25,096,000
28,584,000
31,693,000
26,896,000
27,068,000
24,603,000
25,987,000
22,729,000
24,248,000
20,134,000
16,418,000
10,163,000
10,934,000
9,016,000
8,678,000
8,395,000
13,635,000
13,144,000
10,255,000
11,550,000
12,494,000
10,302,000
7,352,000
7,483,000
6,882,000
5,557,000
4,194,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.